key: cord-1052441-l62aewid
authors: Martins, A. F.; Zavascki, A. P.; Wink, P. L.; Volpato, F. C. Z.; Monteiro, F. L.; Rosset, C.; de-Paris, F.; Ramos, A. K.; Barth, A. L.
title: Detection of SARS-CoV-2 lineage P.1 in patients from a region with exponentially increasing hospitalization rates in February 2021, Rio Grande do Sul, Southern Brazil
date: 2021-03-12
journal: nan
DOI: 10.1101/2021.03.09.21253204
sha: 73a2fdf8407626a20be9561a5c1e2b3ab41425ae
doc_id: 1052441
cord_uid: l62aewid

The emergence SARS-CoV-2 P.1 lineage has been coincidental with a rapid growth in hospitalization in the northern region of Brazil. An exponential growth of severe COVID-19 occurred in Rio Grande do Sul state, Southern Brazil in February-2021. Whole-genome sequencing revealed that the previously undetected P.1 lineage accounted for 88.9% of specimens collected from patients at a referral COVID-19 hospital. These findings raise concerns regarding a possible association between lineage P.1 and rapid growth in cases and hospitalizations.

The state of Amazonas, Northern Brazil, has been hit hardest by COVID-19 among all regions in the country. The first wave was mostly driven by lineage B. 1.195 , which was subsequently replaced by B.1.1.28 [1] . A second wave with striking exponential growth in hospitalizations and deaths has been observed since mid-December 2020, and has been shown to coincide with the emergence of the P.1 variant of concern (VOC), which was first detected in a Brazilian traveler from Amazonas to Japan on January 2, 2021 [2] . Rio Grande do Sul (RS) is the southernmost Brazilian state. With a population of 11,422,973 and land borders with Uruguay and Argentina, it was one of the least affected states during the first wave (early July-September 2020), although the toll increased markedly from early November to late December 2020 [3] . A previous study conducted in the municipality of Esteio, RS, from May to October 2020 revealed that the most common lineages were B.1.1.33 and B.1.1.248 [4] . Genomic surveillance by the central state laboratory confirmed the predominance of these lineages across RS, following a distribution similar to that observed in other Brazilian states, but revealed that lineage P.2, first detected in October 2020, had been gradually replacing these as the predominant variant as of 31 January 2021 [5] . Lineage P.1 was first detected in a single clinical specimen (of 23 collected in the year 2021 to date) obtained on 01 February 2021 from a resident of Gramado, a popular tourist destination in RS, who however had no history of travel or contact with returning travelers from Northern Brazil [6] .

Since epidemiological week 6, starting 07 February 2021, RS has witnessed exponential growth of hospitalizations for COVID-19, from 1738 inpatients on 07 February to 6995 on 06 March-a 3.8-fold increase in the number of hospitalized patients with COVID-19 ( Figure 1 ), resulting in collapse of the regional health system. Since community transmission of lineage P.1 was documented in a highly visited RS municipality one week before the exponential increase in hospitalizations ( Figure 1 ), we decided to investigate whether the P.1 VOC could be detected in specimens from patients hospitalized on February 2021 and compare our findings with specimens obtained in January 2021 and the previous year from a large tertiary care center in the state capital, Porto Alegre, which has been designated as a COVID-19 referral center. perpetuity. preprint (which was not certified by peer review) is the author/funder, who has granted medRxiv a license to display the preprint in for N1 and N2 targets, respectively; one-way ANOVA; Figure 2 ).

Until January 2021, the distribution of SARS-CoV-2 lineages observed in patients treated at our COVID-19 referral center was similar to that observed in regional reports, which tended to follow the distribution of most Brazilian regions, except for the North, where lineage P.1 had been predominant since December [5, 8] . In February 2021, however, an overwhelming increase in hospitalizations has been observed since epidemiological week 6, coinciding temporally with the finding that lineage P.1 became predominant, accounting for the vast majority of specimens selected for genotyping in this period.

Since the hospitalization dynamics observed in Rio Grande do Sul resemble those noted in December in the Northern states, where P.1 vastly predominated among tested specimens, we hypothesize that P.1 might be at least partially associated with the striking rise in hospitalization in Rio Grande do Sul. Previous findings suggesting that P.1 may be more transmissible than other lineages corroborate our hypothesis [1, 8, 9] . Social behavior and the lack of strict COVID-19 control measures in RS, as in other Brazilian states, might have been the perfect scenario for dissemination of a more transmissible SARS-CoV-2 VOC.

Our data have limitations and must be interpreted accordingly. First, our sample comprises patients from a single referral center, and the specimens were chosen by convenience; thus, they should not be interpreted as a prevalence study for our region. Nonetheless, it should be noted that the criteria for specimen selection of isolates from January (one P.1) and February All rights reserved. No reuse allowed without permission. perpetuity. preprint (which was not certified by peer review) is the author/funder, who has granted medRxiv a license to display the preprint in The copyright holder for this this version posted March 12, 2021. ; https://doi.org/10.1101/2021.03.09.21253204 doi: medRxiv preprint 2021 (24 P.1) were the same. Second, although consistent with previous findings [1, 9] , the lower Ct values observed in February must be interpreted with caution, because Ct values were not adjusted for time from onset of symptoms.

In summary, our findings raise concerns regarding a possible association between lineage P.1 and rapid growth in cases and hospitalizations. Despite the relatively low number of specimens analyzed, the finding that the previously undetected P.1 lineage now accounts for almost 90% of specimens from a COVID-19 referral hospital in a state where exponential growth in hospitalizations has been observed warrants close attention and highlights the need for VOC surveillance. Further studies are necessary to investigate the potential association of P.1 dissemination with rapid increase in hospitalizations. 

This study was approved by the Ethics Committees from Hospital de Clínicas de Porto Alegre (CAAE: 30767420.2.0000.5327).

We thank the staff of "Laboratório de Diagnóstico de SARS-CoV-2" as well as the staff of the Hospital Infection Committee of our institution ("Hospital de Clínicas de Porto Alegre") for providing data used in this study. perpetuity. preprint (which was not certified by peer review) is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. preprint (which was not certified by peer review) is the author/funder, who has granted medRxiv a license to display the preprint in The copyright holder for this this version posted March 12, 2021. ; https://doi.org/10.1101/2021.03.09.21253204 doi: medRxiv preprint

COVID-19 epidemic in the Brazilian state of Amazonas was driven by long-term persistence of endemic SARS-CoV-2 lineages and the recent emergence of the new Variant of Concern P.1. Research Square

Novel SARS-CoV-2 variant identified in travelers from Brazil to Japan

Vigilância Genômica do SARS-CoV-2 no Brasil

Research Square

lineage assignment in an emerging pandemic as an epidemiological tool

Genomics and epidemiology of a novel SARS-CoV-2 lineage in Manaus

Modelbased evaluation of transmissibility and reinfection for the P.1 variant of the SARS-CoV-2. medRxiv

All rights reserved. No reuse allowed without permission. perpetuity. preprint (which was not certified by peer review) is the author/funder, who has granted medRxiv a license to display the preprint in preprint (which was not certified by peer review) is the author/funder, who has granted medRxiv a license to display the preprint inThe copyright holder for this this version posted March 12, 2021. ; https://doi.org/10.1101/2021.03.09.21253204 doi: medRxiv preprint